Neither Roche Chairman Franz Humer nor CEO Severin Schwan have called me up to ask how I’d handle the talent side of their Genentech acquisition. Perhaps they will, but they’ve also been pretty mum on their plans moving forward for the talent at 1 DNA Way .
As someone who has made their livelihood in the talent assessment business as a coach to managers and teams for over 25 years – and to save Franz and Severin a long distance phone call charge – here are some things I’d be thinking about if I were on point with the talent side of the Genentech project.… Read the rest